Landmark analysis at the 25-year landmark point

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 3, 2011, Pages 363-371

  Dafni, Urania ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Clinical trials; Observational studies; Prognostic factors; Time to event outcome; Time varying covariate

Indexed keywords

CLOPIDOGREL;

ANALYTIC METHOD; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR SURGERY; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CORONARY ARTERY RECANALIZATION; DATA ANALYSIS; DEFIBRILLATOR; DRUG ELUTING STENT; HAZARD RATIO; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LANDMARK ANALYSIS METHOD; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZATION; RISK REDUCTION; SIMULATION; STATISTICAL DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, STATISTICAL; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PROBABILITY; PROGNOSIS; RESEARCH DESIGN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79959728931     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.957951     Document Type: Article

References (29)

1. Anderson JR, Cain KC, Gelber RD Analysis of survival by tumor response J Clin Oncol 1983;1:710-719. (Pubitemid 14202071)
2. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 2007;297: 159-168. (Pubitemid 46089732)
3. Gail MH Does Cardiac Transplantation Prolong Life? A reassessment Ann Intern Med 1972;76:815-871.
4. Clark DA, Stinson EB, Griepp RB, Schroeder JS, Shumway NE, Harrison DC Cardiac transplantation in man, VI: prognosis of patients selected for cardiac transplantation Ann Intern Med 1971;75:15-21.
5. Mantel N, Byar DP Evaluation of response-time data involving transient states: an illustration using heart-transplant data J Am Stat Assoc 1974; 69:81-86.
6. Weiss GB, Bunce H III, Hokanson JA Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials Control Clin Trials 1983;4:43-52. (Pubitemid 13065044)
7. Anderson JR, Davis RB Analysis of survival by tumor response J Clin Oncol 1986;4:115-117.
8. Snapinn S, Jiang Q, Iglewicz B Statistical practice illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator Am Stat 2005;59:301-307. (Pubitemid 41616828)
9. Anderson JR, Cain KC, Gelber RD Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables J Clin Oncol 2008;26:3913-3915.
10. Bertino JR Guidelines for reporting clinical trials J Clin Oncol 1986;4:1.
11. Simon R, Wittes RE Methodologic guidelines for reports of clinical trials Cancer Treat Rep 1985;69:1-3. (Pubitemid 15197067)
12. Methodologic guidelines for reports of clinical trials Am J Clin Oncol 1986;9:276.
13. Johnson JR, Temple R Food and Drug Administration requirements for approval of new anticancer drugs Cancer Treat Rep 1985;69: 1155-1157. (Pubitemid 16239319)
14. Moreton P, Kennedy B, Lucas G, Leach M, Rassam SMB, Haynes A, Tighe J, Oscier D, Fegan C, Rawstron A, Hillmen P Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival J Clin Oncol 2005;23:2971-2979. (Pubitemid 46224116)
15. Anderson JR, Neuberg DS Analysis of outcome by response flawed J Clin Oncol 2005;23:8122-8123.
16. Windecker S, Meier B Late coronary stent thrombosis Circulation 2007;116:1952-1965. (Pubitemid 350287091)
17. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 2009;2:16-24.
18. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW Time to coronary angiography and outcomes among patients with high-risk non-ST-segment-elevation acute coronary syndromes: results from the SYNERGY Trial Circulation 2007;116:2669-2677. (Pubitemid 350291239)
19. Buyse M, Piedbois P On the relationship between response to treatment and survival time Stat Med 1996;15:2797-2812. (Pubitemid 27011058)
20. Advanced Colorectal Cancer Meta-Analysis ProjectMeta-analysis of randomized trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer J Clin Oncol 1994;12: 960-969.
21. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS Outcomes following coronary stenting in the era of bare-metal vs the era of drugeluting stents JAMA 2008;299:2868-2876. (Pubitemid 351930886)
22. Kramer MCA, Van der Wal AC, Koch KT, Ploegmakers JPHM, Van der Schaaf RJ, Henriques JPS, Baan J, Rittersma SZH, Vis MM, Piek JJ, Tijssen, De Winter RJ Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention Circulation 2008;118: 1810-1816.
23. Cox DR Regression models and life tables (with discussion) J R Stat Soc Ser B 1972;34:187-220.
24. Simon R, Makuch RW A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias Stat Med 1984; 3:35-44. (Pubitemid 14142275)
25. Johnson BA, Tsiatis AA Semiparametric inference in observational duration-response studies, with duration possibly right-censored Biometrika 2005;92:605-618. (Pubitemid 41241596)
26. Nam CM, Zelen M Comparing the survival of two groups with an intermediate clinical event Lifetime Data Anal 2001;7:5-19. (Pubitemid 33692872)
27. Normand SLT Evaluating the optimal timing of angiography: landmark or off the mark? Circulation 2007;116:2656-2657.
28. Mauri L, Normand S-L Studies of drug-eluting stents: to each his own? Circulation 2008;117:2047-2050. (Pubitemid 351572166)
29. R Development Core TeamR: A Language and Environment for tatistical ComputingVienna, Austria: R Foundation for Statistical Computing; 2005 ISBN 3-900051-07-0http://www.R-project.org.